MedTrace Logo

Effectiveness of XCell on Autolytic Debridement of Venous Ulcers

NCT00446823 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2007-03-13

No results posted yet for this study

Summary

This clinical trial is designed to evaluate the effect of XCell cellulose wound dressing for its ability to naturally (autolytically) remove nonviable tissue and create a healthy vascular wound bed. Results will compare venous ulcers treated with Xylos XCell cellulose dressing plus standard care to those treated with standard care alone. The hypothesis is that XCell will demonstrate more autolytic debridement than the standard of care.

Conditions

  • Venous Ulcer

Interventions

DEVICE

XCell cellulose wound dressing

DEVICE

Impregnated gauze dressing

Sponsors & Collaborators

  • Xylos Corporation

    lead INDUSTRY

Principal Investigators

  • Oscar M Alvarez, Ph.D. · University Wound Clinics, LLC

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2002-06-30
Completion
2003-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00446823 on ClinicalTrials.gov